Search results
Novavax awaits FDA decision on whether its next COVID shot can be offered in US By Reuters
Investing.com· 1 day agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 4 days agoThe FLiRT variants are new strains of COVID-19 that begin with either KP or JN, and they’re named...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 3 days agoThe stock, however, keeps going up. Moderna...-based vaccines, were up 21% on Wednesday. Shares of ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 2 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoNovavax has its own unique "nano-particle" protein-based approach to vaccines that's different from Moderna and BioNTech and has attempted ...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 2 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Biz: Club at Atlantic Beach builds for new era; Raleigh restaurant asks for help - Triangle Business...
The Business Journals· 2 days agoBeachgoers to Atlantic Beach this Memorial Day weekend will see that an ocean-front club that has...
Penn Researchers Develop Experimental mRNA Avian F | Newswise
Newswise· 3 days agoPHILADELPHIA— An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models. The
3 Biotech Stocks to Buy Now: May 2024
InvestorPlace· 3 days agoWhile it tends to fly under the radar for many people, the biotech industry has seen a resurgence in investor interest over the last couple of years....